Outcome	O
Measures	O

The	O
primary	O
outcome	O
was	O
all	B-PrimaryOutcome
-	I-PrimaryOutcome
cause	I-PrimaryOutcome
mortality	I-PrimaryOutcome
within	B-TimeFrame
28	I-TimeFrame
days	I-TimeFrame
after	I-TimeFrame
randomization	I-TimeFrame
;	I-TimeFrame
further	I-TimeFrame
analyses	I-TimeFrame
were	I-TimeFrame
specified	I-TimeFrame
at	I-TimeFrame
6	I-TimeFrame
months	I-TimeFrame
.	O

Secondary	O
outcomes	O
were	O
the	O
time	B-SecondaryOutcome
until	I-SecondaryOutcome
discharge	I-SecondaryOutcome
from	I-SecondaryOutcome
the	I-SecondaryOutcome
hospital	I-SecondaryOutcome
and	O
,	O
among	O
patients	O
not	O
receiving	O
invasive	O
mechanical	O
ventilation	O
at	O
the	O
time	O
of	O
randomization	O
,	O
subsequent	B-SecondaryOutcome
receipt	I-SecondaryOutcome
of	I-SecondaryOutcome
invasive	I-SecondaryOutcome
mechanical	I-SecondaryOutcome
ventilation	I-SecondaryOutcome
(	I-SecondaryOutcome
including	I-SecondaryOutcome
extracorporeal	I-SecondaryOutcome
membrane	I-SecondaryOutcome
oxygenation	I-SecondaryOutcome
)	I-SecondaryOutcome
or	I-SecondaryOutcome
death	I-SecondaryOutcome
.	O

Other	O
prespecified	O
clinical	O
outcomes	O
included	O
cause	B-OtherOutcome
-	I-OtherOutcome
specific	I-OtherOutcome
mortality	I-OtherOutcome
,	O
receipt	B-OtherOutcome
of	I-OtherOutcome
renal	I-OtherOutcome
dialysis	I-OtherOutcome
or	I-OtherOutcome
hemofiltration	I-OtherOutcome
,	O
major	B-OtherOutcome
cardiac	I-OtherOutcome
arrhythmia	I-OtherOutcome
(	O
recorded	O
in	O
a	O
subgroup	O
)	O
,	O
and	O
receipt	B-OtherOutcome
and	I-OtherOutcome
duration	I-OtherOutcome
of	I-OtherOutcome
ventilation	I-OtherOutcome
.	O

Among	O
those	O
receiving	O
invasive	O
mechanical	O
ventilation	O
at	O
the	O
time	O
of	O
randomization	O
,	O
the	O
outcome	O
of	O
successful	O
cessation	O
of	O
invasive	O
mechanical	O
ventilation	O
was	O
defined	O
as	O
cessation	B-OutcomeDefinition
within	I-OutcomeDefinition
(	I-OutcomeDefinition
and	I-OutcomeDefinition
survival	I-OutcomeDefinition
to	I-OutcomeDefinition
)	I-OutcomeDefinition
28	I-OutcomeDefinition
days	I-OutcomeDefinition
.	O

All	O
information	O
presented	O
in	O
this	O
report	O
is	O
based	O
on	O
a	O
data	O
cutoff	O
of	O
December	O
14	O
,	O
2020	O
.	O

Information	O
regarding	O
the	O
primary	O
and	O
secondary	O
outcomes	O
is	O
complete	O
for	O
99	O
.	O
9	O
%	O
of	O
trial	O
participants	O
.	O

